Contact us

521 Results:

Sort By:

Guided by evidence-based care in the use of human milk-based nutrition in the NICU: Learning from the past

Type: Prolacta in the News

Topic(s): Quality & Safety

Sinai Chicago is first safety net NICU to address health inequity gap by adopting an EHMD

Type: Prolacta in the News

Topic(s): Company Feeding Intolerance Mortality

Human breastmilk fortifiers may ward off eye disease in premature babies, finds Prolacta-backed study

Type: Prolacta in the News

Topic(s): Retinopathy of Prematurity (ROP)

Four studies showed Prolacta Bioscience’s 100% human milk-based fortifiers reduced retinopathy of prematurity (ROP) in premature infants

Type: Press Releases

Topic(s): Retinopathy of Prematurity (ROP)

Baby Crew achieves healthy growth with Prolacta's fortifiers

Type: Parent Stories

Topic(s): Parents

Gloria Crockett, senior director of quality

Type: Employee Stories

Topic(s): Company Quality & Safety

Use of an exclusive human milk diet in preterm infants to lower healthcare costs – short-term and long-term perspectives

Type: Prolacta in the News

Topic(s): Cost Savings / Cost Effectiveness Long-Term outcomes Pasteurization

Prolacta Bioscience provides update on latest SARS-CoV-2 data and continued safety of its human milk-based nutritional products

Type: Press Releases

Topic(s): Quality & Safety

Prolacta’s manufacturing team shines in 2020

Type: Employee Stories

Topic(s): Quality & Safety

Not finding the reference you’re looking for?

Email us at info@prolacta.com